Literature DB >> 12202405

What is polycystic ovary syndrome? Are national views important?

Adam Balen1, Kathy Michelmore.   

Abstract

Polycystic ovary syndrome (PCOS) is a true syndrome, being a heterogeneous collection of signs and symptoms that gathered together form a spectrum of a disorder with a mild presentation in some, whilst in others there is a severe disturbance of reproductive, endocrine and metabolic function. There has been much debate about phenotype and, more recently, genotype. There has also been scepticism in some quarters, with a feeling that we may be looking at one end of a spectrum that is in reality 'normal', or perhaps a consequence of the modern disease of obesity. Whilst the polycystic ovary is at the centre of the syndrome, it is external effects such as hyperinsulinism, that influence its expression. There is no consensus on the definition of PCOS and so studies that compare epidemiology and treatments often have very different starting points, and so cannot be compared. In this debate we wish to re-explore our current thinking on PCOS, with a particular emphasis on the British and European perspective and invite others to contribute to the discussion which could form the basis for an international consensus.

Entities:  

Mesh:

Year:  2002        PMID: 12202405     DOI: 10.1093/humrep/17.9.2219

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

1.  Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status.

Authors:  Qing Peng; Carrie A Karvonen-Gutierrez; John F Randolph; Bin Nan; Daniel McConnell; Siobán D Harlow
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 2.  Managing anovulatory infertility and polycystic ovary syndrome.

Authors:  Adam H Balen; Anthony J Rutherford
Journal:  BMJ       Date:  2007-09-29

3.  Should obese women with polycystic ovary syndrome receive treatment for infertility?

Authors:  Adam H Balen; Martin Dresner; Eleanor M Scott; James O Drife
Journal:  BMJ       Date:  2006-02-25

Review 4.  MR features of physiologic and benign conditions of the ovary.

Authors:  Ken Tamai; Takashi Koyama; Tsuneo Saga; Aki Kido; Masako Kataoka; Shigeaki Umeoka; Shingo Fujii; Kaori Togashi
Journal:  Eur Radiol       Date:  2006-05-31       Impact factor: 5.315

5.  Alteration in follistatin gene expression detected in prenatally androgenized rats.

Authors:  Marziyeh Salehi Jahromi; Fahimeh Ramezani Tehrani; Jennifer W Hill; Mahsa Noroozzadeh; Maryam Zarkesh; Asghar Ghasemi; Azita Zadeh-Vakili
Journal:  Gynecol Endocrinol       Date:  2017-02-26       Impact factor: 2.260

6.  Outcome of ovarian drilling in women with polycystic ovary syndrome.

Authors:  Niraj K Yanamandra; Sirisha Rao Gundabattula
Journal:  J Clin Diagn Res       Date:  2015-02-01

7.  Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

Authors:  Nike M M L Stikkelbroeck; Ad R M M Hermus; Diana Schouten; Harold M Suliman; Gerrit J Jager; Didi D M Braat; Barto J Otten
Journal:  Eur Radiol       Date:  2004-08-18       Impact factor: 5.315

Review 8.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08

9.  Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial.

Authors:  Neriman Bayram; Madelon van Wely; Eugenie M Kaaijk; Patrick M M Bossuyt; Fulco van der Veen
Journal:  BMJ       Date:  2004-01-24

10.  Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement.

Authors:  Marla E Lujan; Donna R Chizen; Andrew K Peppin; Anita Dhir; Roger A Pierson
Journal:  J Ovarian Res       Date:  2009-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.